ZY Insider Trading Activity and SEC Form 4 Filings
ZY insider trading summary
No open-market insider purchases or sales of Zymergen Inc. (ZY) have been reported on SEC Form 4 in the past 12 months.
Latest ZY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 3, 2022 | Enakshi Singh | Chief Financial Officer | Sell | $11K (3,786 @ $2.80) |
| Sep 2, 2022 | Zachariah Serber | Chief Science Officer | Sell | $7K (3,268 @ $2.21) |
| Sep 2, 2022 | Mina Kim | Chief Legal Officer | Sell | $8K (3,410 @ $2.21) |
| Sep 2, 2022 | Enakshi Singh | Chief Financial Officer | Sell | $9K (3,928 @ $2.21) |
| Aug 30, 2022 | Enakshi Singh | Chief Financial Officer | Sell | $35K (15,365 @ $2.27) |
| Aug 11, 2022 | Zachariah Serber | Chief Science Officer | Sell | $21K (5,435 @ $3.91) |
| Aug 2, 2022 | Mina Kim | Chief Legal Officer | Sell | $8K (3,094 @ $2.61) |
| Aug 2, 2022 | Zachariah Serber | Chief Science Officer | Sell | $8K (2,966 @ $2.61) |
| Jul 5, 2022 | Mina Kim | Chief Legal Officer | Sell | $4K (2,924 @ $1.32) |
| Jul 5, 2022 | Zachariah Serber | Chief Science Officer | Sell | $4K (2,797 @ $1.32) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.